
On July 16, the FDA approved enlicitide (brand name Lipfendra) to lower LDL cholesterol in people with high cholesterol. For people with very high cholesterol, this is a big deal. We have known since the late 1950’s that elevated cholesterol was associated with an increased risk of heart attack, but the drugs then available […] Read more »








